Endo Tools Therapeutics SA: Enabling Natural Orifice GI Procedures

Belgium-based Endo Tools Therapeutics SA is developing devices that will enable NOTES procedures to treat disorders such as type 2 diabetes, morbid obesity, and digestive tract tumors. Its Endomina device is a universal, multi-channel triangulation platform for use on any existing endoscope through the natural orifices, such as the esophagus.

Belgium-based Endo Tools Therapeutics SA aims to enable natural orifice translumenal endoscopic surgery (NOTES) for treating disorders such as type 2 diabetes, morbid obesity, and digestive tract tumors. Its Endomina is a universal triangulation platform for use with any existing endoscope through the natural orifices, such as the mouth and esophagus. The single-use, flexible device consists of two therapeutic hollow channels that attach to a standard endoscope after insertion in the patient’s stomach. It allows for multiple small tools such as a small-tissue grasper, an electric tissue cutter, or a needle for a suture to be introduced and removed during a procedure, with up to three tools used at the same time. At the end of the channels, Endomina also features two arms that are silicon-enclosed and controlled via joysticks to ensure independent control and position reset. The tip of the device replicates the movements from the joysticks to perform remote surgical actions. In addition, movements are transmitted using mechanical wires in Endomina to avoid any electricity flow in the patient. (See Also see "Obesity Intervention: A New Era Of Discovery And Innovation" - Medtech Insight, 7 December, 2012., Also see "Trends In MIS, Part I: Pushing Surgical Boundaries" - Medtech Insight, 25 May, 2012., Also see "Trends In MIS: Part II" - Medtech Insight, 6 July, 2012., and Also see "The Future of Laparoscopy: Single Incision, NOTES and Robots " - Medtech Insight, 1 July, 2010..)

“We can make very complex movements – suturing, lifting tissues – in the patient, without resorting to laparoscopy or open surgery,” says Alexandre Chau, PhD, Endo Tools’ CEO. Both plastic...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight

Edwards Lifesciences Holds 2025 EPS Outlook Despite Tariff Headwind

 
• By 

The brunt of the tariff exposure stems from Singapore and Costa Rica, which together account for an estimated 70% to 80% of the tariff-related cost burden. Less than 10% of the exposure is tied to China.

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By 

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.